Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.

Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.

Item
http://www.wikidata.org/entity/Q50955712
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesRegulation of tumour necrosis factor signalling: live or let dieCD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitisQuantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assayBlimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.TNF blocking therapies and immunomonitoring in patients with inflammatory bowel diseaseCultured blood T-cell responses predict anti-TNF therapy response in patients with ulcerative colitis.Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis.Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
P2860

Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.

Item
http://www.wikidata.org/entity/Q50955712
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
type
label
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
prefLabel
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
Infliximab inhibits activation ...... lly active ulcerative colitis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Infliximab inhibits activation ...... lly active ulcerative colitis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698